Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. OTC Bulletin Board
  5. Anavex Life Sciences Corp
  6. News
  7. Summary
    AVXL   US0327971026

ANAVEX LIFE SCIENCES CORP

(AVXL)
End-of-day quote OTC Bulletin Board  -  01:11 2022-12-09 am EST
- USD    0.00%
12/06Top Midday Decliners
MT
12/06Cantor Fitzgerald Downgrades Anavex Life Sciences to Neutral From Overweight, Adjusts Price Target to $11 From $16
MT
12/05ANAVEX2-73 (Blarcamesine) Phase 2B/3 Study Met Primary and Key Secondary Endpoints, Showing Statistically Significant Reduction of Clinical Decline in Global Clinical Study of Patients
AQ
SummaryNewsRatingsCalendarCompanyFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about ANAVEX LIFE SCIENCES CORP
12/06Cantor Fitzgerald Downgrades Anavex Life Sciences to Neutral From Overweight, Adjusts P..
MT
12/05ANAVEX2-73 (Blarcamesine) Phase 2B/3 Study Met Primary and Key Secondary Endpoints, Sho..
AQ
12/05Transcript : Anavex Life Sciences Corp. - Special Call
CI
12/02Anavex Life Sciences to Announce Management Webcast and Conference Calláon Monday Decem..
AQ
12/02Top Midday Gainers
MT
12/02Anavex Life Sciences Says Trial of Alzheimer's Disease Drug Candidate Met Primary, Seco..
MT
12/02Sector Update: Health Care Stocks Lean Lower Pre-Bell Friday
MT
12/02Sector Update: Health Care
MT
12/02Anavex Life Sciences : Filed herewith - Form 8-K
PU
12/02Anavex Life Sciences Says Trial of Alzheimer's Disease Drug Candidate Met Primary, Seco..
MT
12/01ANAVEX«2–73 (Blarcamesine) Phase 2B/3 Study Met Primary and Key Secondary Endpoin..
AQ
12/01ANAVEX«2–73 (Blarcamesine) Phase 2B/3 Study Met Primary and Key Secondary Endpoint..
CI
12/01Anavex Life Sciences : «2-73 (blarcamesine) phase 2b/3 study met primary and key secondary..
PU
11/28Anavex Life Sciences Corp. Reports Earnings Results for the Full Year Ended September 3..
CI
11/28Anavex Life Sciences Shares Fall After it Reports Wider Fiscal Q4 Loss
MT
More most relevant news
All news about ANAVEX LIFE SCIENCES CORP
12/06Top Midday Decliners
MT
12/06Cantor Fitzgerald Downgrades Anavex Life Sciences to Neutral From Overweight, Adjusts P..
MT
12/05ANAVEX2-73 (Blarcamesine) Phase 2B/3 Study Met Primary and Key Secondary Endpoints, Sho..
AQ
12/05Transcript : Anavex Life Sciences Corp. - Special Call
CI
12/05Maison Luxe ($MASN) revenues grew 35% compared to the quarter ended September 30, 2021
AQ
12/02Anavex Life Sciences to Announce Management Webcast and Conference Calláon Monday Decem..
AQ
12/02Sector Update: Health Care Stocks Rise Friday
MT
12/02Top Midday Gainers
MT
12/02Sector Update: Health Care Stocks Trim Morning Declines, Paced by Biotechs
MT
12/02Anavex Life Sciences Says Trial of Alzheimer's Disease Drug Candidate Met Primary, Seco..
MT
More news
News in other languages on ANAVEX LIFE SCIENCES CORP
12/06Principales baisses à la mi-journée
12/02Mise à jour sectorielle : Les actions du secteur de la santé aug..
12/02Principaux gagnants de la mi-journée
12/02Mise à jour sectorielle : Les actions du secteur de la santé réd..
12/02Anavex Life Sciences déclare que l'essai du médicament candidat contre la maladie d'Alz..
12/02Mise à jour sectorielle : Les actions du secteur de la santé son..
12/02Le robuste rapport sur l'emploi de novembre ne donne pas d'élan aux futures actions amé..
12/02Mise à jour sectorielle : Soins de santé
12/02La prudence avant le rapport sur l'emploi de novembre pèse sur les fonds négociés en bo..
12/02Principaux gagnants du pré-marché
More news
Analyst Recommendations on ANAVEX LIFE SCIENCES CORP
12/06Cantor Fitzgerald Downgrades Anavex Life Sciences to Neutral From Overweight, Adjusts P..
MT
06/23Berenberg Bank Initiates Coverage on Anavex Life Sciences With Buy Rating, $40 Price Ta..
MT
02/02HC Wainwright Adjusts Anavex Life Sciences' Price Target to $42 from $39, Keeps Buy Rat..
MT
2021Anavex Life Sciences : BTIG Starts Anavex Life Sciences at Buy with..
MT
2021Anavex Life Sciences : HC Wainwright Adjusts Price Target on Anavex..
MT
More recommendations
Press releases
12/05ANAVEX2-73 (Blarcamesine) Phase 2B/3 Study Met Primary and Key Secondary Endpoints, Sho..
AQ
12/05Maison Luxe ($MASN) revenues grew 35% compared to the quarter ended September 30, 2021
AQ
12/02Anavex Life Sciences to Announce Management Webcast and Conference Calláon Monday Decem..
AQ
12/02Anavex Life Sciences : Filed herewith - Form 8-K
PU
12/02Anavex Life Sciences Corp. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
More press releases
Upcoming event on ANAVEX LIFE SCIENCES CORP